For several years now medical experts from the University of Bonn have been clocking up largely positive experience with what is known as medihoney. “In hospitals today we are faced with germs which are resistant to almost all the current antibiotics,” explains Dr. Arne Simon, physician at Bonn University Children’s Clinic. “As a result, the medical use of honey is becoming attractive again for the treatment of wounds.”
Medihoney bears the CE seal for medical products; its quality is regularly tested. Two dozen hospitals in Germany are using honey in their treatment of wounds. Despite all the success there have hitherto been very few reliable clinical studies of its effectiveness. In conjunction with colleagues from Düsseldorf, Homburg and Berlin, the Bonn medical staff now want to remedy this. With the Woundpecker Data Bank, which they have developed themselves, they will be recording and evaluating over 100 courses of disease over the next few months. The next step planned is comparative studies with other therapeutic methods such as the very expensive cationic silver dressings.
It has already been proved that medihoney even puts paid to multi-resistant germs such as MRSA. In this respect medihoney is neck and neck in the race to beat the antibiotic mupirocin, currently the local MRSA antibiotic of choice. This is shown by a study recently published by researchers in Australia. In one point medihoney was even superior to its rival: the bacteria did not develop any resistance to the natural product during the course of treatment.
It is also known today why honey has an antiseptic effect: when producing honey, bees add an enzyme called glucose-oxidase. This enzyme ensures that small amounts of hydrogen peroxide, an effective antiseptic, are constantly being formed from the sugar in the honey. The advantage over the hydrogen peroxide from the chemist’s is that small concentrations are sufficient to kill the germs, as it is constantly being produced.
MEDICA.de; Source: Bonn University